Literature DB >> 8362429

Silent infarcts in patients with ischemic stroke are related to age and size of the left atrium.

F Mounier-Vehier1, D Leys, P Rondepierre, O Godefroy, J P Pruvo.   

Abstract

BACKGROUND AND
PURPOSE: Possible specific risk factors for silent infarcts remain unknown. The aim of this study was to investigate whether risk factors for silent infarcts differ from those for symptomatic infarcts in stroke patients.
METHODS: Silent infarcts were defined as asymptomatic infarcts detected on computed tomographic scan in patients free of history of stroke and unrelated to the symptoms and signs of the index stroke. Of 595 consecutive patients with stroke or transient ischemic attacks, 116 (19%) had at least one silent infarct on the first computed tomographic scan performed within 24 hours after onset. They were compared with the 479 remaining patients for cerebrovascular risk factors and for presumed mechanism of stroke by means of the odds ratio method. A discriminant analysis was then performed in the subgroup of 216 patients with ischemic stroke who underwent an exhaustive cardiac and vascular workup.
RESULTS: One hundred forty-one silent infarcts (99% confidence interval [CI], 29% to 41%) and 265 symptomatic infarcts (99% CI, 59% to 71%) were subcortical infarcts smaller than 15 mm. Univariate analysis showed that patients with silent infarcts were more likely to be older than 65 years (odds ratio [99% CI], 1.11 to 3.49) and to have left atrial enlargement on echocardiogram (odds ratio [99% CI], 1.02 to 26.70) and leukoaraiosis (odds ratio [99% CI], 1.39 to 4.21). Discriminant analysis found only two independent risk factors for silent infarcts: left atrial enlargement (P = .007) and age older than 65 years (P = .03); leukoaraiosis was not found to be an independent risk factor (P = .86).
CONCLUSIONS: Age and left atrial enlargement are the main risk factors for silent infarcts in patients with ischemic stroke or transient ischemic attacks.

Entities:  

Mesh:

Year:  1993        PMID: 8362429     DOI: 10.1161/01.str.24.9.1347

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Influence of cognitive impairment on the institutionalisation rate 3 years after a stroke.

Authors:  M Pasquini; D Leys; M Rousseaux; F Pasquier; H Hénon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-04       Impact factor: 10.154

3.  Early epileptic seizures after stroke are associated with increased risk of new-onset dementia.

Authors:  Charlotte Cordonnier; Hilde Hénon; Philippe Derambure; Florence Pasquier; Didier Leys
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05       Impact factor: 10.154

4.  Prestroke dementia in patients with atrial fibrillation. Frequency and associated factors.

Authors:  C Lefebvre; D Deplanque; E Touzé; H Hénon; L Parnetti; F Pasquier; V Gallai; D Leys
Journal:  J Neurol       Date:  2005-07-18       Impact factor: 4.849

5.  Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.

Authors:  Jeff S Healey; David J Gladstone; Balakumar Swaminathan; Jens Eckstein; Hardi Mundl; Andrew E Epstein; Karl Georg Haeusler; Robert Mikulik; Scott E Kasner; Danilo Toni; Antonio Arauz; George Ntaios; Graeme J Hankey; Kanjana Perera; Jorge Pagola; Ashfaq Shuaib; Helmi Lutsep; Xiaomeng Yang; Shinichiro Uchiyama; Matthias Endres; Shelagh B Coutts; Michal Karlinski; Anna Czlonkowska; Carlos A Molina; Gustavo Santo; Scott D Berkowitz; Robert G Hart; Stuart J Connolly
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

6.  Small subcortical infarcts and primary subcortical haemorrhages may have different risk factors.

Authors:  E Janssens; F Mounier-Vehier; M Hamon; D Leys
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

Review 7.  Implications of silent strokes.

Authors:  Frank M Yatsu; Hashem M Shaltoni
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

8.  Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia.

Authors:  H Hénon; F Pasquier; I Durieu; J P Pruvo; D Leys
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

9.  Cognitive Impairment After Stroke.

Authors:  Pushpendra Nath Renjen; Charu Gauba; Dinesh Chaudhari
Journal:  Cureus       Date:  2015-09-29

10.  Phenotypes of Chronic Covert Brain Infarction in Patients With First-Ever Ischemic Stroke: A Cohort Study.

Authors:  Jan Vynckier; Johannes Kaesmacher; Urs Fischer; Thomas Raphael Meinel; Joanna Marguerite Wardlaw; Laurent Roten; Morin Beyeler; Nebiyat Filate Belachew; Lorenz Grunder; David Julian Seiffge; Simon Jung; Jan Gralla; Tomas Dobrocky; Mirjam Rachel Heldner; Ulrike Prange; Martina Béatrice Goeldlin; Marcel Arnold
Journal:  Stroke       Date:  2021-09-16       Impact factor: 7.914

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.